Published in Public Health Rep on April 01, 2010
Grading quality of evidence and strength of recommendations. BMJ (2004) 26.08
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med (2003) 15.48
Controlling tuberculosis in India. N Engl J Med (2002) 8.98
Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med (2006) 7.68
Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep (2002) 6.51
Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA (2008) 6.13
Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet (2006) 5.56
Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis (2002) 5.23
A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med (2002) 4.88
Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999. Clin Infect Dis (2002) 4.08
Interventions to prevent skin cancer by reducing exposure to ultraviolet radiation: a systematic review. Am J Prev Med (2004) 4.07
Ounces of prevention--the public policy case for taxes on sugared beverages. N Engl J Med (2009) 3.98
Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010). Clin Infect Dis (2011) 3.46
Cholesterol control beyond the clinic: New York City's trans fat restriction. Ann Intern Med (2009) 3.38
Medication-assisted therapies--tackling the opioid-overdose epidemic. N Engl J Med (2014) 3.35
Asleep at the switch: local public health and chronic disease. Am J Public Health (2004) 3.33
An outbreak of conjunctivitis due to atypical Streptococcus pneumoniae. N Engl J Med (2003) 3.32
Effectiveness of a large-scale distribution programme of free nicotine patches: a prospective evaluation. Lancet (2005) 3.29
Purchasing behavior and calorie information at fast-food chains in New York City, 2007. Am J Public Health (2008) 3.23
Client-directed interventions to increase community demand for breast, cervical, and colorectal cancer screening a systematic review. Am J Prev Med (2008) 3.05
Bacterial meningitis in the United States, 1998-2007. N Engl J Med (2011) 2.99
Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system. BMC Health Serv Res (2005) 2.91
Prevalence and control of diabetes and impaired fasting glucose in New York City. Diabetes Care (2009) 2.82
Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen. Emerg Infect Dis (2002) 2.76
Deaths preventable in the U.S. by improvements in use of clinical preventive services. Am J Prev Med (2010) 2.73
Informed decision making: what is its role in cancer screening? Cancer (2004) 2.52
Tracking diabetes: New York City's A1C Registry. Milbank Q (2009) 2.34
Risk factors for delayed initiation of medical care after diagnosis of human immunodeficiency virus. Arch Intern Med (2008) 2.31
Seasonal patterns of invasive pneumococcal disease. Emerg Infect Dis (2003) 2.29
Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med (2009) 2.25
CDC Health Disparities and Inequalities Report - United States, 2013. Foreword. MMWR Surveill Summ (2013) 2.24
Superspreading SARS events, Beijing, 2003. Emerg Infect Dis (2004) 2.03
Inhalational anthrax outbreak among postal workers, Washington, D.C., 2001. Emerg Infect Dis (2002) 2.03
Increased prevalence of pediatric pneumococcal serotypes in elderly adults. Clin Infect Dis (2005) 2.03
First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities - May 2014. MMWR Morb Mortal Wkly Rep (2014) 2.00
Population prevalence of reported and unreported HIV and related behaviors among the household adult population in New York City, 2004. AIDS (2008) 1.97
Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial. Lancet (2009) 1.95
The scientific basis for law as a public health tool. Am J Public Health (2008) 1.91
Elimination of cholera transmission in Haiti and the Dominican Republic. Lancet (2012) 1.91
Firearms laws and the reduction of violence: a systematic review. Am J Prev Med (2005) 1.86
Childhood obesity in New York City elementary school students. Am J Public Health (2004) 1.85
Seasonality of tuberculosis in India: is it real and what does it tell us? Lancet (2004) 1.84
Study design and participation rates of the New York City Health and Nutrition Examination Survey, 2004. Prev Chronic Dis (2006) 1.83
Integrating evidence-based clinical and community strategies to improve health. Am J Prev Med (2007) 1.82
Rapid DOTS expansion in India. Bull World Health Organ (2002) 1.81
Trends and racial/ethnic disparities in gestational diabetes among pregnant women in New York City, 1990-2001. Am J Public Health (2005) 1.75
Perinatal infections due to group B streptococci. Obstet Gynecol (2004) 1.69
Declining incidence of invasive Streptococcus pneumoniae infections among persons with AIDS in an era of highly active antiretroviral therapy, 1995-2000. J Infect Dis (2005) 1.68
Changes in invasive Pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization. Ann Intern Med (2006) 1.67
Free nicotine patch giveaway program 12-month follow-up of participants. Am J Prev Med (2006) 1.66
Prevalence, awareness, treatment, and predictors of control of hypertension in New York City. Circ Cardiovasc Qual Outcomes (2008) 1.63
Some methodologic lessons learned from cancer screening research. Cancer (2004) 1.60
An overview of 9/11 experiences and respiratory and mental health conditions among World Trade Center Health Registry enrollees. J Urban Health (2008) 1.60
Adherence to antimicrobial inhalational anthrax prophylaxis among postal workers, Washington, D.C., 2001. Emerg Infect Dis (2002) 1.59
Disease surveillance and the academic, clinical, and public health communities. Emerg Infect Dis (2003) 1.58
Global strategies to prevent bacterial pneumonia in adults with HIV disease. Lancet Infect Dis (2004) 1.57
Secondhand smoke exposure among nonsmokers nationally and in New York City. Nicotine Tob Res (2009) 1.54
Opening a bacillus anthracis-containing envelope, Capitol Hill, Washington, D.C.: the public health response. Emerg Infect Dis (2002) 1.53
Public health in Haiti--challenges and progress. N Engl J Med (2011) 1.53
Population-based surveillance for postpartum invasive group a streptococcus infections, 1995-2000. Clin Infect Dis (2002) 1.53
Demographic and behavioral factors associated with daily sugar-sweetened soda consumption in New York City adults. J Urban Health (2008) 1.52
Obesity and diabetes in New York City, 2002 and 2004. Prev Chronic Dis (2008) 1.51
Contributions of a local health examination survey to the surveillance of chronic and infectious diseases in New York City. Am J Public Health (2008) 1.51
Impact of conjugate vaccine on transmission of antimicrobial-resistant Streptococcus pneumoniae among Alaskan children. Pediatr Infect Dis J (2008) 1.50
Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. Lancet Infect Dis (2003) 1.49
Risk factors for SARS among persons without known contact with SARS patients, Beijing, China. Emerg Infect Dis (2004) 1.48
Invasive group A streptococcal disease: risk factors for adults. Emerg Infect Dis (2003) 1.48
The effectiveness of early childhood home visitation in preventing violence: a systematic review. Am J Prev Med (2005) 1.47
Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. Pediatrics (2002) 1.47
Promoting evidence-based public health policy: can we have better evidence and more action? Health Aff (Millwood) (2006) 1.44
Benefits from immunization during the vaccines for children program era - United States, 1994-2013. MMWR Morb Mortal Wkly Rep (2014) 1.44
Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska. J Infect Dis (2004) 1.43
Public health detailing: a strategy to improve the delivery of clinical preventive services in New York City. Public Health Rep (2006) 1.43
Risk factors for invasive, early-onset Escherichia coli infections in the era of widespread intrapartum antibiotic use. Pediatrics (2006) 1.41
The global tuberculosis situation. Progress and problems in the 20th century, prospects for the 21st century. Infect Dis Clin North Am (2002) 1.39
Severe acute respiratory syndrome, Beijing, 2003. Emerg Infect Dis (2004) 1.37
Nonadherence to breast and cervical cancer screening: what are the linkages to chronic disease risk? Prev Chronic Dis (2003) 1.35
Ethics in public health research: privacy and public health at risk: public health confidentiality in the digital age. Am J Public Health (2008) 1.34
Socioeconomic and racial/ethnic disparities in the incidence of bacteremic pneumonia among US adults. Am J Public Health (2010) 1.33
Prevention of invasive pneumococcal disease among HIV-infected adults in the era of childhood pneumococcal immunization. AIDS (2010) 1.32
Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework. Bull World Health Organ (2002) 1.29
Smoking practices in New York City: the use of a population-based survey to guide policy-making and programming. J Urban Health (2005) 1.27
Risk factors for invasive pneumococcal disease in children in the era of conjugate vaccine use. Pediatrics (2010) 1.26
Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment. Lancet (2005) 1.23
Interventions to improve influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among high-risk adults: a systematic review. Am J Prev Med (2005) 1.22
Evaluation of the phenol ammonium sulfate sedimentation smear microscopy method for diagnosis of pulmonary tuberculosis. J Clin Microbiol (2002) 1.21
Local knowledge to enable local action. Am J Prev Med (2004) 1.21
Vaccination and perinatal infection prevention practices among obstetrician-gynecologists. Obstet Gynecol (2003) 1.19
The future of research that promotes cancer screening. Cancer (2004) 1.18
The use of chlorhexidine to reduce maternal and neonatal mortality and morbidity in low-resource settings. Int J Gynaecol Obstet (2007) 1.17
Perinatal group B streptococcal disease. Best Pract Res Clin Obstet Gynaecol (2007) 1.17
Inefficiency of 0.3% carbol fuchsin in ziehl-neelsen staining for detecting acid-fast bacilli. J Clin Microbiol (2002) 1.16
Serotype distribution and antibiotic susceptibility of invasive and nasopharyngeal isolates of Streptococcus pneumoniae among children in rural Mozambique. Trop Med Int Health (2006) 1.15
Early experience with human papillomavirus vaccine introduction in the United States, Canada and Australia. Vaccine (2008) 1.15
Prevalence of tuberculin skin test positivity and conversions among healthcare workers in New York City during 1994 to 2001. Infect Control Hosp Epidemiol (2003) 1.15
Risk factors for pediatric invasive group A streptococcal disease. Emerg Infect Dis (2005) 1.15
Prenatal screening for infectious diseases and opportunities for prevention. Obstet Gynecol (2003) 1.14
Severe pneumonia in Mozambican young children: clinical and radiological characteristics and risk factors. J Trop Pediatr (2009) 1.13
Classical and latent class analysis evaluation of sputum polymerase chain reaction and urine antigen testing for diagnosis of pneumococcal pneumonia in adults. J Infect Dis (2003) 1.13